Arzeda Awarded DARPA Funding to Advance AI-Driven Protein Design for National Security

SEATTLE: DARPA Backs Arzeda’s AI Platform to Create Novel Proteins with Limited Data SEATTLE, Jan. 23, 2025 /PRNewswire/ — Arzeda, the industry-leading Protein Design Company™, today announced it has been selected for an award from the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) under its Artificial Intelligence (AI) Biotechnology (AI BTO) initiative. The award follows on the heels of the announcement of co-founder David Baker’s 2024 Nobel Prize in Chemistry for pioneering work in computational protein design.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top